Current evidence for use of robotic exoskeletons in rehabilitation

Arun Jayaraman, Borislav Marinov, Yashna Singh, Sheila Burt, William Zev Rymer

Research output: Chapter in Book/Report/Conference proceedingChapter

9 Scopus citations


Despite the rapid development of exoskeletons in recent years, the clinical use of exoskeleton technology remains limited, and people with neurological disability rely primarily on other sources of mobility such as wheelchairs and orthoses. Although some studies have demonstrated the safety and efficacy of the four Food and Drug Administration-approved rigid exoskeletons and longer term studies are underway, it remains unclear as to whether these devices are effective medically, whether they are the best choice to provide standing or locomotor therapy, and whether they are cost-effective compared to current standards of care. In this chapter, we briefly review the history of exoskeletons and discuss the current state of evidence on their clinical use. We explore several constraints and difficulties associated with the development of strong evidence-based data sets justifying the use of exoskeletons. We also highlight ways future clinical trials and research studies can help clinicians determine which device and approach is best for use in therapy.

Original languageEnglish (US)
Title of host publicationWearable Robotics
Subtitle of host publicationSystems and Applications
Number of pages10
ISBN (Electronic)9780128146590
ISBN (Print)9780128146606
StatePublished - Jan 1 2019


  • Clinical evidence
  • Exoskeletons
  • Neurorehabilitation
  • Spinal cord injury
  • Stroke

ASJC Scopus subject areas

  • General Biochemistry, Genetics and Molecular Biology


Dive into the research topics of 'Current evidence for use of robotic exoskeletons in rehabilitation'. Together they form a unique fingerprint.

Cite this